A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Letermovir USP Related Compound B | CAS 2991059-71-1 - Solicitar cotización

media.product.imagealternatetextformat.details

Letermovir USP Related Compound B

N° de SZ CAT: SZ-L052020
Número CAS
2991059-71-1
Mol.F.
C29H28F4N4O5
Peso Molecular
588.6
Status de Fatura
Synthesis on demand

Nome Químico :

Temperatura de envío :

Código HSN :

País de origen :

Sorrisos :

Proporción CHNS (%) :

Nota de Uso:

Letermovir USP Related Compound B is chemically (S)-4-{4-(Carboxymethyl)-8-fluoro-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-2-yl}-1-(3-methoxyphenyl)piperazine 1-oxide (as per USP). Letermovir USP Related Compound B is supplied with detailed characterization data compliant with regulatory guideline. Letermovir USP Related Compound B can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Letermovir.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Aplicaciones y casos de uso regulatorios

Comprar 2991059-71-1

Comprar 2991059-71-1

Encomendar 2991059-71-1

Consultar 2991059-71-1

price of 2991059-71-1

2991059-71-1 Fornecedor

2991059-71-1 Fabricante

2991059-71-1 Exportador

buy high quality Letermovir USP Related Compound B

Comprar Letermovir USP Related Compound B

Letermovir USP Related Compound B fornecedores

Letermovir USP Related Compound B fabricantes

Letermovir USP Related Compound B preço

Encomendar Letermovir USP Related Compound B

Consultar Letermovir USP Related Compound B

Letermovir USP Related Compound B custo

Letermovir USP Related Compound B Fornecedor

Letermovir USP Related Compound B Distribuidor

Letermovir USP Related Compound B Para validación de métodos

Letermovir Estándar de referencia

Letermovir USP Related Compound B Para presentación ANDA

Letermovir USP Related Compound B Para estudios de degradación forzada

Letermovir USP Related Compound B Estándares de identificación

Letermovir USP Related Compound B Para presentación DMF

ℹ️

Isenção de responsabilidade

As informações do produto SynZeal fornecidas neste site são baseadas no entendimento existente no momento da publicação. O cliente é responsável por avaliar a precisão das informações no momento da compra.

A SynZeal atualizará estes detalhes conforme novos desenvolvimentos ou descobertas nas especificações do produto, sem aviso prévio.

Notice

Date:

Location: